Martin Maier
125Patents
19h-index
66Co-inventors
89Inventor score
Filing activity: Feb 12, 1999 → Oct 8, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8106022B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 229 | Active |
| US8828956B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 160 | Active |
| US8450467B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 145 | Active |
| US8642076B2 | Lipid containing formulations | Human Necessities | 138 | Active |
| US9352048B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 99 | Active |
| US9012498B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 94 | Active |
| US9051567B2 | Methods for increasing efficacy of lipid formulated siRNA | Chemistry; Metallurgy | 92 | Active |
| US8999351B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 91 | Active |
| US9290760B2 | Modified iRNA agents | Chemistry; Metallurgy | 90 | Active |
| US9796974B2 | Modified RNAi agents | Chemistry; Metallurgy | 85 | Active |
| US6207819A | Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds | Chemistry; Metallurgy | 55 | Expired |
| US8034376B2 | Lipid containing formulations | Human Necessities | 41 | Active |
| US7713944B2 | Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells | Human Necessities | 37 | Expired |
| US9682922B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 36 | Active |
| US9399775B2 | RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases | Chemistry; Metallurgy | 29 | Active |
| US9682139B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 28 | Active |
| US9061063B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 27 | Active |
| US9867882B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 23 | Active |
| US10233448B2 | Modified double-stranded RNA agents | Chemistry; Metallurgy | 21 | Active |
| US6878805B2 | Peptide-conjugated oligomeric compounds | Chemistry; Metallurgy | 19 | Expired |
| US10369226B2 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 19 | Active |
| US9370581B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 18 | Active |
| US9370582B2 | Carbohydrate conjugates as delivery agents for oligonucleotides | Emerging Cross-Sectional Technologies | 17 | Active |
| US10612027B2 | Modified double-stranded RNA agents | Chemistry; Metallurgy | 15 | Active |
| US11246933B1 | Biodegradable lipids for the delivery of active agents | Chemistry; Metallurgy | 14 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.